Peter D Aplan

12PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicineHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 22, 2026
A complex mutational signature generated by cytarabine resistance.

|Jul 18, 2025
5-Azacytidine and decitabine induce C > G transversions in both murine and human cells.

Ryan Bertoli, Dengchao Cao, Olivia Tuckey

|Jun 25, 2025
Mechanism of cytarabine-induced neurotoxicity.

Jia-Cheng Liu, Dongpeng Wang, Elsa Callen

|Jan 09, 2025
Advancing drug development in myelodysplastic syndromes.

Alain Mina, Kathy L McGraw, Lea Cunningham

|Jun 04, 2024
The DNA Methyltransferase Inhibitor 5-Aza-4'-thio-2'-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia Development.

Ryan M Bertoli, Yang Jo Chung, Michael J Difilippantonio

|Feb 24, 2024
The evolution of preclinical models for myelodysplastic neoplasms.

Alain Mina, Steven Pavletic, Peter D Aplan

Pageof 2

Frequent Collaborators

4 joint publications

Paul S Meltzer

3 joint publications

Yuelin Zhu

2 joint publications

Michael J Difilippantonio

2 joint publications

Haley Klimaszewski